Mitochondrial aconitase (ACO2) modulates iron homeostasis and is associated with outcomes in poor prognosis aggressive non-small cell lung cancer
Ontology highlight
ABSTRACT: NSCLC accounts for 85% of lung cancers, the most frequently diagnosed and leading cause of cancer related death. An ACO2-iron acis regulates intracellular iron and consequently the particularly aggressive phenotype associated with NSCLC engraftment and poor prognosis. These findings suggest that NSCLC stratified by ACO2 protein level may benefit from treatments that target iron homeostasis.
INSTRUMENT(S): LTQ Orbitrap, Q Exactive HF
ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)
TISSUE(S): Lung, Epithelial Cell
DISEASE(S): Non-small Cell Lung Carcinoma
SUBMITTER: Shideh Mirhadi
LAB HEAD: Michael F. Moran
PROVIDER: PXD028556 | Pride | 2022-09-19
REPOSITORIES: Pride
ACCESS DATA